CCB International: Funding, Team & Investors | Startup Intros

Loading organizations...

CCB International: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 16, 2021	IASO Biotherapeutics	$108.0M Series C	Wei Ying	China Everbright, Plaisance Capital Management
Aug 1, 2021	SVOLT	$1.6B Series B	Bank of China Group Investment	China Renaissance, Country Garden Venture Capital, Guotou Chuangye, IDG Capital, JZ Capital, Oceanpine Capital, Shenzhen Capital Group, Sub-funds of National Fund for Technology Transfer and Commercialization, Xiaomi
Jul 22, 2021	Geneplus-Beijing Co. Ltd.	$115.9M Beijing Co. Ltd. - Series C	CCB International	—
Mar 24, 2021	Shanghai Cell Therapy Group	$76.7M Series D	—	Haier Capital, Jiuzhou Venture
Jul 2, 2020	XSKY Data Technology	$45.3M Other Equity	Capital One Ventures	iMotion Automotive Technology
Mar 18, 2020	Immunocore	$130.0M Series B	Rob Perez	Bill & Melinda Gates Foundation, Eli Lilly and Company, JDRF T1D Fund, Rock Springs Capital, RTW Investments, Terra Magnum Capital Partners, WuXi AppTec
Dec 16, 2019	WeLab	$156.0M Series C	—	Alibaba Entrepreneurs Fund
Jul 18, 2018	Ascentage Pharma	$150.0M Series C	Teng Yue Partners, Lawrence Tian	ArrowMark Partners, CTS Capital, HDY International Investment
Aug 15, 2016	Firefly Games	$10.0M Other Equity	CCB International	Credit China FinTech